Evaluation and Management of Post-CABG Burning Feet with Resting Tremor
This patient requires urgent evaluation for peripheral neuropathy with focused workup including nerve conduction studies, vitamin B12/folate levels, thyroid function, and neuroimaging to rule out Parkinson's disease given the new resting tremor, while simultaneously addressing potential vascular causes with ankle-brachial index and arterial duplex ultrasound.
Immediate Diagnostic Priorities
Neurologic Evaluation
The combination of bilateral burning feet unresponsive to gabapentinoids plus a new resting tremor in a 70-year-old post-CABG patient demands immediate neurologic assessment. The resting tremor raises concern for:
- Parkinson's disease (most likely given age and unilateral resting tremor)
- Critical illness polyneuropathy (can occur post-cardiac surgery 1)
- Drug-induced tremor (gabapentinoids themselves can cause tremor 2)
Vascular Assessment
Despite being non-diabetic, post-CABG patients require peripheral artery disease (PAD) evaluation. In patients with PAD presenting with new lower extremity signs or symptoms, ABI and arterial duplex ultrasound is recommended 3. The burning sensation could represent:
- Ischemic neuropathy from PAD
- Saphenous nerve injury from vein harvesting (occurred in 13 of 421 CABG patients in one series 4)
- Common peroneal neuropathy (8 of 421 post-CABG patients 4)
Specific Workup Algorithm
First-Line Tests (Order Immediately)
- Nerve conduction studies/EMG - differentiate between axonal vs demyelinating neuropathy
- ABI with arterial duplex ultrasound - rule out PAD 3
- Vitamin B12, folate, methylmalonic acid - common reversible causes
- TSH, free T4 - thyroid dysfunction causes neuropathy
- Comprehensive metabolic panel - uremia, electrolyte abnormalities
- HbA1c - confirm non-diabetic status (prediabetes can cause neuropathy)
Second-Line Tests (Based on Initial Results)
- Brain MRI - if tremor suggests Parkinson's or other CNS pathology
- Neurology consultation - for tremor evaluation and consideration of DaTscan if Parkinson's suspected
- Serum protein electrophoresis, immunofixation - if EMG suggests demyelinating pattern
- Heavy metal screening - if occupational exposure history
Management Strategy
Medication Adjustment
Stop gabapentinoids immediately. Gabapentin/pregabalin have limited efficacy in non-diabetic peripheral neuropathy and pregabalin specifically increases heart failure risk (AHR 1.48, even higher at 1.85 in cardiovascular disease patients 5). This is critical in a post-CABG hypertensive patient.
Alternative Pain Management
Based on 2025 AHA guidelines 6:
- Supervised exercise therapy (Class I indication) - improves pain through mechanisms beyond hemodynamics (inflammation reduction, mitochondrial function)
- Cilostazol (Class I indication) - if PAD confirmed, increases maximal walking distance
- NSAIDs - target nociceptive component, but use cautiously given cardiovascular disease and hypertension
- Duloxetine or tricyclic antidepressants - if neuropathic component confirmed, though evidence is inconclusive 6
Tremor Management
- Do not treat tremor empirically until diagnosis established
- If Parkinson's confirmed: levodopa/carbidopa
- If drug-induced: discontinue offending agent (gabapentinoid)
- If essential tremor: propranolol (but avoid in severe PAD)
Critical Pitfalls to Avoid
- Assuming non-diabetic status excludes neuropathy - many causes exist (B12 deficiency, hypothyroidism, uremia, medications)
- Overlooking saphenous nerve injury - extremely common post-CABG (13% developed PNS complications, with saphenous neuropathy being frequent 4)
- Continuing gabapentinoids indefinitely - they increase cardiovascular risk and have uncertain efficacy in this population 6, 5
- Ignoring the tremor - this is a new neurologic sign requiring separate evaluation; it may be unrelated to the burning feet
- Missing PAD - post-CABG patients have systemic atherosclerosis; burning feet can represent claudication equivalent 3
Longitudinal Follow-Up
Coordinate care among cardiology, neurology, and vascular medicine 3. Post-CABG patients require:
- Periodic clinical evaluation of lower extremity symptoms and pulse assessment 3
- Assessment of functional status and quality of life 3
- Long-term guideline-directed medical therapy to prevent major adverse cardiovascular and limb events 3
- If PAD confirmed with revascularization: ABI and duplex ultrasound at 1-3 months, 6 months, 12 months, then annually 3
Smoking Cessation
Mandatory intervention. Smoking is the single most modifiable risk factor exacerbating both neuropathy and PAD. Refer to smoking cessation program immediately.